$MTD

Mettler-Toledo (MTD) Q2 2026 Earnings Call Transcript

Mettler-Toledo (MTD) reported Q2 2026 net sales of $1.027B, up 4% reported (6% local currency). Adjusted EPS was $11.46, up 14%. Adjusted operating margin was 29.3%. The company raised full-year 2026 guidance to 4% to 5% local currency revenue growth and adjusted EPS of $47.15 to $47.50, and plans $875M share repurchases.

Original reporting
Published Aug 8, 2026, 4:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 8, 2026, 4:55 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Mettler-Toledo (MTD) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$MTDBullishHigh
01

Why it matters

The key tradable items are the raised full-year sales and adjusted EPS outlook, the Q3 adjusted EPS range, and the increased planned share repurchases, all supported by margin expansion and China outperformance. Risks include tariff normalization and geopolitical-driven customer decision delays.

02

Market read

Traders can update 2026 EPS expectations based on the explicit guidance ranges and assess buyback-driven support, while monitoring tariff and geopolitics risks.

03

What to watch

Middle East volatility is noted as a potential demand headwind, and currency effects are explicitly called out as a driver of margin variability.

Relevance 9/10Novelty 9/10Timing: pre-market today (earnings call transcript dated Jul. 31, 2026)

Background

This is a Q2 2026 earnings call transcript for Mettler-Toledo, covering segment organic growth, margins, and updated 2026 and Q3 guidance.

Company-level read

Ticker impact

$MTDBullishHigh confidence
Context

Mettler-Toledo reported Q2 net sales of $1.027B and raised full-year 2026 revenue and adjusted EPS guidance, including $875M planned buybacks.

Expected impact

Bullish bias for the next few sessions as traders reprice 2026 EPS and buyback expectations, tempered by tariff refund normalization risk.

Evidence & confidence

The article discloses specific Q2 results and explicit updated full-year and Q3 adjusted EPS ranges, plus a larger planned repurchase program. It also flags Middle East volatility and tariff-related items that could affect future demand and reported earnings.

Market effects

Signals continued demand strength in lab instrumentation and industrial automation, potentially supporting sentiment across precision instruments and lab workflow software/services.

China organic sales exceeded guidance (9%), while emerging markets ex-China grew in high single digits, reinforcing a multi-region recovery narrative.

Tariff refund benefit and tariff-rate commentary highlight ongoing trade-policy sensitivity for precision equipment makers with global customer bases.

Counterpoint

Tariff refunds boosted reported EPS, so the market may overreact if future tariff impacts are not similarly offset.

Key entities

  • Mettler-Toledo International Inc.

    Reported Q2 results and raised full-year 2026 guidance, citing China strength, productivity, and LabX recurring service growth.

  • Patrick Kaltenbach

    CEO who attributed China growth to industrial segment strength and discussed biopharma onshoring momentum.

  • Shawn Vadala

    CFO who provided guidance ranges and highlighted Middle East volatility as a risk factor.

Related articles

$MTDMed

5 Insightful Analyst Questions From Mettler

Mettler-Toledo (MTD) reported Q2 revenue of $1.03B, matching analyst estimates, with 4.5% YoY growth. Adjusted EPS was $11.46 versus $10.81 expected, and operating margin rose to 30.6%. Management raised full-year Adjusted EPS guidance to $47.33 midpoint. Analysts focused on China demand, lab rebound durability, pricing, and biopharma/reshoring momentum.

$MTDHighAI 9/10

MTD Q2 FY2026 earnings call — BigGo Finance

Mettler-Toledo (MTD) reported Q2 FY2026 revenue of $1.0B, up 7% YoY (6% local currency), beating prior guidance. Adjusted EPS rose 14% to $11.46. Organic local-currency sales grew 4%, with acquisitions ~1.5%. The company raised full-year outlook to 4% to 5% local-currency sales growth and adjusted EPS of $47.15 to $47.50.

$MTDMed

Toledo (NYSE:MTD) Reports Q2 CY2026 In Line With Expectations

Precision measurement company Mettler-Toledo (NYSE: MTD) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 4.5% year on year to $1.03 billion. Its non-GAAP profit of $11.46 per share was 6.1% above analysts’ consensus estimates. Is now the time to buy Mettler-Toledo? Find out by accessing our full research report, it’s free.

$MTDHigh

METTLER TOLEDO INTERNATIONAL INC/ (MTD): Results of Operations and Financial Condition

METTLER TOLEDO INTERNATIONAL INC/ (MTD) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex-991mtd8xkq22026.htm EX-99.1 Document FOR IMMEDIATE RELEASE Exhibit 99.1 METTLER-TOLEDO INTERNATIONAL INC. REPORTS SECOND QUARTER 2026 RESULTS COLUMBUS, Ohio, USA – July 30, 2026 – Mettler-Toledo International Inc. (NYSE: MTD) today announced second quarter results fo

$DLXMed

Deluxe Q2 Earnings Call Highlights

Deluxe (NYSE:DLX) reported Q2 segment results, led by Data Solutions revenue up 21.4% to $82.3M and adjusted EBITDA of $18.1M. Merchant Services revenue rose 6.1% to $107.6M. Print revenue fell 4.3% to $235.9M. Deluxe closed its Celero acquisition on July 31 and raised 2026 guidance: revenue $2.095B-$2.12B, adj. EBITDA $455M-$475M, adj. EPS $3.60-$4.00, and FCF about $200M.